It’s a choice of subscription or one time purchase

Because you just run a script in poweshell and it gives you a legit licence. There have even been reported cases of Microsoft support advising to use the script when a customer has a licence issue.

One has a stinger and one incubates eggs I guess?

Does that mean it wouldn’t be an issue if you bring an SSL cert from say ZeroSSL but use Cloudflare for DNS, caching, DDoS protection etc?

They’ve got EA Sports FC (formerly FIFA) and madden though, they’re never going to die.

Yeah for sure, I think the user had to provide keys in the latest Yuzu anyway?

It was donation builds with support for tears of the kingdom before released that screwed the project. The code itself was legal afaik.

My understanding is the prod keys are required to tell the software (e.g. games) that it is running on an authorised device and passes certain checks / DRM.

To run the software without prod keys would require (I think) patching each game individually to skip those checks. So it could be possible but wildly impractical unless some other work around is found.

Buy one get one free though - it’s actually 24 x 330ml for £15

Makes sense, but I’m fairly sure that would be a February 2024 release :)

I like The Lounge

She’s Irish, and has possibly one of the most Irish names I’ve ever seen.

Nah he hasn’t mentioned using the brake at all. It’s only for short stops though.

There is a bite point where you don’t need to use the brake at all, just clutch and accelerator in perfect harmony. With practice you’ll be able to stay perfectly still, or inch forwards or backwards even on steep hills.

It does get tiring if you have to hold it too long though.

Go underarm, more biomechanically friendly

Ever met a 30 year old squirrel? Idk to be honest I have no idea how long they live

This is absolutely the way to go, but be aware that it can lead to concentration/sectoral risk when managers aren’t aware of positions in the other portfolios. For example, Goldman could invest heavily in tech or pharma or whatever, not realising that JPM also have a big investment in that area.